{"id":"W2038822008","doi":"10.1097/01.jto.0000284054.96114.bf","title":"P3-078: MO19390: an open-label safety study of bevacizumab in combination with chemotherapy as first-line treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)","year":2007,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Bevacizumab; Medicine; Carboplatin; Chemotherapy; Internal medicine; Oncology; Regimen; Chemotherapy regimen; Clinical endpoint; Lung cancer; Surgery; Clinical trial; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002012671,0.002033799,0.003773482,0.0009564876,0.0007017914,0.001437261,0.001359607,0.0024099,0.005251899],"category_scores_gemma":[0.001613028,0.001032823,0.00228062,0.0007514456,0.00171299,0.001670416,0.0004683626,0.006347764,0.001157115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001651597,"about_ca_system_score_gemma":0.002558505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002313438,"about_ca_topic_score_gemma":0.005127423,"domain_scores_codex":[0.9989774,0.0005318093,0.00004216379,0.0001902006,0.00009783835,0.0001605246],"domain_scores_gemma":[0.9987813,0.0002521047,0.0002775834,0.00008225721,0.00006550372,0.0005413182],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9002821,0.02810042,0.003396069,0.0004544825,0.002002848,0.0001807598,0.0001238745,0.001004653,0.01547352,0.0002221586,0.00274125,0.04601791],"study_design_scores_gemma":[0.6943324,0.2916897,0.006820546,0.00002897766,0.001102759,0.0002184644,0.00003816648,0.001280035,0.002547803,0.0001364051,0.001761016,0.00004367495],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908591,0.002279685,0.0005651004,0.0007357408,0.0002208559,0.001302397,0.001824664,0.0001958004,0.002016687],"genre_scores_gemma":[0.9898669,0.001789919,0.001100956,0.0008206068,0.0004099132,0.001374408,0.002026246,0.00007403281,0.00253705],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005251899,"threshold_uncertainty_score":0.0175693,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02302581308160304,"score_gpt":0.4326784761061702,"score_spread":0.4096526630245672,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}